| Q38992057 | A cadherin switch underlies malignancy in high-grade gliomas. |
| Q90390155 | A potential Rho GEF and Rac GAP for coupled Rac and Rho cycles during mesenchymal-to-epithelial-like transitions |
| Q37334258 | A quest for initiating cells of head and neck cancer and their treatment |
| Q47303095 | Activated HGF-c-Met Axis in Head and Neck Cancer |
| Q42801184 | Adherens junction treadmilling during collective migration. |
| Q33799224 | AlphaE-catenin regulates actin dynamics independently of cadherin-mediated cell-cell adhesion |
| Q33474847 | Alteration of gene expression signatures of cortical differentiation and wound response in lethal clear cell renal cell carcinomas |
| Q37676762 | Altered expression of fibroblast growth factor receptor 2 isoform IIIc: relevance to endometrioid adenocarcinoma carcinogenesis and histological differentiation |
| Q26852158 | Anoikis molecular pathways and its role in cancer progression |
| Q89737185 | BIRC7 promotes epithelial-mesenchymal transition and metastasis in papillary thyroid carcinoma through restraining autophagy |
| Q36204798 | Biologic characteristics of premalignant breast disease |
| Q81556375 | Breaking down EMT |
| Q36658798 | Bridging the Gap: From 2D Cell Culture to 3D Microengineered Extracellular Matrices |
| Q37368971 | Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective |
| Q47130831 | Cancer cell-soluble factors reprogram mesenchymal stromal cells to slow cycling, chemoresistant cells with a more stem-like state. |
| Q42006656 | Cancer stem cell markers in head and neck squamous cell carcinoma. |
| Q34250491 | Cellular and molecular processes leading to embryo formation in sponges: evidences for high conservation of processes throughout animal evolution. |
| Q35643796 | Changes in glomerular parietal epithelial cells in mouse kidneys with advanced age |
| Q28085565 | Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies |
| Q33678275 | Chronic inflammation and cytokines in the tumor microenvironment |
| Q26741429 | Circulating Tumor Cells in the Adenocarcinoma of the Esophagus |
| Q36105474 | Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes |
| Q35486869 | Clinical implication of CD166 expression in salivary gland tumor. |
| Q38073630 | Collective cell migration of epithelial and mesenchymal cells |
| Q35032720 | Comprehensive proteome quantification reveals NgBR as a new regulator for epithelial-mesenchymal transition of breast tumor cells |
| Q41831928 | Computational modeling of single-cell migration: the leading role of extracellular matrix fibers |
| Q39031238 | Critical role of miR-10b in transforming growth factor-β1-induced epithelial-mesenchymal transition in breast cancer |
| Q38025331 | Current state of the development of mesenchymal stem cells into clinically applicable Schwann cell transplants |
| Q28506916 | Deficiency in Crumbs homolog 2 (Crb2) affects gastrulation and results in embryonic lethality in mice |
| Q97094004 | Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma |
| Q37737205 | Differential MicroRNA Expression Between Gastric Cancer Tissue and Non-cancerous Gastric Mucosa According to Helicobacter pylori Status |
| Q42407375 | Diversity in the molecular and cellular strategies of epithelium-to-mesenchyme transitions: Insights from the neural crest. |
| Q35853987 | Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer. |
| Q37151282 | Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer |
| Q50528588 | Driving Cancer Tumorigenesis and Metastasis Through UPR Signaling. |
| Q42134280 | Dynamic analysis of the mesenchymal-epithelial transition of blood-brain barrier forming glia in Drosophila |
| Q37855367 | Dynamics of adherens junctions in epithelial establishment, maintenance, and remodeling |
| Q29040399 | Early Regression of the Dental Lamina Underlies the Development of Diphyodont Dentitions |
| Q37360395 | Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation |
| Q50188901 | Emodin inhibits colon cancer cell invasion and migration by suppressing epithelialmesenchymal transition via the Wnt/β-catenin pathway. |
| Q26830155 | Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease |
| Q37507462 | Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models |
| Q35951834 | Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation |
| Q39090188 | Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases |
| Q38044317 | Epithelial to mesenchymal transition as a portal to stem cell characters embedded in gene networks. |
| Q57283456 | Epithelial-mesenchymal transition and cancer stem cells: at the crossroads of differentiation and dedifferentiation |
| Q37620379 | Epithelial-mesenchymal transition in development and cancer |
| Q37164129 | Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. |
| Q57395176 | Epithelial–mesenchymal transition of epicardial mesothelium is a source of cardiac CD117-positive stem cells in adult human heart |
| Q50592669 | Evaluation of aldehyde dehydrogenase 1 and transcription factors in both primary breast cancer and axillary lymph node metastases as a prognostic factor. |
| Q33815175 | Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma |
| Q21135539 | Evidence for mesenchymal-epithelial transition associated with mouse hepatic stem cell differentiation |
| Q41947542 | Evidence for partial epithelial-to-mesenchymal transition (pEMT) and recruitment of motile blastoderm edge cells during avian epiboly |
| Q37481495 | Examination of Epithelial Mesenchymal Transition in Keloid Tissues and Possibility of Keloid Therapy Target |
| Q37726627 | Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer |
| Q91893044 | Fluid shear stress coupled with narrow constrictions induce cell type-dependent morphological and molecular changes in SK-BR-3 and MDA-MB-231 cells |
| Q38460765 | Generation of cardiac progenitor cells through epicardial to mesenchymal transition. |
| Q38103747 | Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cells |
| Q26742115 | Glycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition? |
| Q40045355 | Hedgehog signaling in biliary fibrosis |
| Q37811158 | Hedgehog signaling in the liver |
| Q42430169 | High tumor-associated macrophages infiltration is associated with poor prognosis and may contribute to the phenomenon of epithelial-mesenchymal transition in gastric cancer |
| Q35841951 | Human epicardium: ultrastructural ancestry of mesothelium and mesenchymal cells |
| Q33872063 | Imaging cell shape change in living Drosophila embryos |
| Q53558609 | Immunoexpression of tenascin as a predictor of the malignancy potential of oral leukoplakia associated with a tobacco habit. |
| Q39421834 | Immunolocalization of endocan during the endothelial-mesenchymal transition process |
| Q28475341 | In Vitro Transformation of Primary Human CD34+ Cells by AML Fusion Oncogenes: Early Gene Expression Profiling Reveals Possible Drug Target in AML |
| Q37118924 | Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells |
| Q38737715 | Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma. |
| Q38756929 | Is there any role of epithelial to mesenchymal transition in the pathogenesis of contrast nephropathy? |
| Q38204716 | Isoforms of receptors of fibroblast growth factors |
| Q39429617 | Isolation and characterization of stem-like cells from a human ovarian cancer cell line |
| Q36974720 | Kaposi's sarcoma-associated herpesvirus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin |
| Q41836547 | Lamellipodia-based migrations of larval epithelial cells are required for normal closure of the adult epidermis of Drosophila |
| Q36179588 | LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis |
| Q36228782 | Lithium Attenuates TGF-β(1)-Induced Fibroblasts to Myofibroblasts Transition in Bronchial Fibroblasts Derived from Asthmatic Patients |
| Q33405240 | Liver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumor suppression to epithelial-mesenchymal transition |
| Q51772947 | Long Non-coding RNA HOXA11 Antisense Promotes Cell Proliferation and Invasion and Predicts Patient Prognosis in Serous Ovarian Cancer. |
| Q90317219 | Long non-coding RNA linc00645 promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-205-3p-ZEB1 axis in glioma |
| Q37565430 | MT2-MMP induces proteolysis and leads to EMT in carcinomas |
| Q21562167 | Matrix Rigidity Regulates Cancer Cell Growth and Cellular Phenotype |
| Q33804105 | Mechanisms of the epithelial-mesenchymal transition by TGF-beta |
| Q92840367 | Membranous staining of β-catenin and E-cadherin expression in patients with gastric cancer |
| Q34504623 | Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers |
| Q46236135 | MicroRNA-23a promotes pancreatic cancer metastasis by targeting epithelial splicing regulator protein 1. |
| Q91756456 | MicroRNA-410-3p upregulation suppresses proliferation, invasion and migration, and promotes apoptosis in rhabdomyosarcoma cells |
| Q37941371 | MicroRNA-mediated breast cancer metastasis: from primary site to distant organs |
| Q37672322 | Molecular bases of cell-cell junctions stability and dynamics |
| Q38207092 | Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte. |
| Q49383041 | Molecular signature of nitric oxide on major cancer hallmarks of colorectal carcinoma |
| Q34895558 | Morphogenetic cell movements: diversity from modular mechanical properties |
| Q38834297 | Moscatilin inhibits epithelial-to-mesenchymal transition and sensitizes anoikis in human lung cancer H460 cells |
| Q30422568 | Mouse primitive streak forms in situ by initiation of epithelial to mesenchymal transition without migration of a cell population |
| Q42580444 | Myosin II promotes the anisotropic loss of the apical domain during Drosophila neuroblast ingression |
| Q92084207 | N3ICD with the transmembrane domain can effectively inhibit EMT by correcting the position of tight/adherens junctions |
| Q48167275 | Neural crest emigration: From start to stop |
| Q36675419 | New spin on an old transition: epithelial parallels in neuronal adhesion control |
| Q43263377 | Nitric oxide suppresses transforming growth factor-beta1-induced epithelial-to-mesenchymal transition and apoptosis in mouse hepatocytes |
| Q40617717 | Notochord morphogenesis in mice: Current understanding & open questions. |
| Q35177151 | Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer |
| Q38355587 | On the move: endocytic trafficking in cell migration. |
| Q30485285 | Oncogenic Ras-transformed human fibroblasts exhibit differential changes in contraction and migration in 3D collagen matrices |
| Q46347453 | Osteoblast migration in vertebrate bone |
| Q38785793 | Overexpression of Livin promotes migration and invasion of colorectal cancer cells by induction of epithelial-mesenchymal transition via NF-κB activation |
| Q90404451 | Oxygen Tension and the VHL-Hif1α Pathway Determine Onset of Neuronal Polarization and Cerebellar Germinal Zone Exit |
| Q39816900 | P-cadherin induces an epithelial-like phenotype in oral squamous cell carcinoma by GSK-3beta-mediated Snail phosphorylation. |
| Q34778528 | PARP-1 regulates metastatic melanoma through modulation of vimentin-induced malignant transformation. |
| Q54411257 | Phenotypic Plasticity of the Ovarian Surface Epithelium: TGF-β1 Induction of Epithelial to Mesenchymal Transition (EMT) in Vitro |
| Q38570239 | Phorbol ester phorbol-12-myristate-13-acetate induces epithelial to mesenchymal transition in human prostate cancer ARCaPE cells |
| Q35145928 | Polarity transitions during neurogenesis and germinal zone exit in the developing central nervous system |
| Q37996455 | Premetastatic niche: ready for new therapeutic interventions? |
| Q48506818 | Primer and interview: epithelial to mesenchymal transition. [Interview by Julie Kiefer]. |
| Q36591911 | Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer |
| Q37194065 | Progress in stem cell-derived technologies for hepatocellular carcinoma |
| Q54193729 | Protein expression and promoter methylation of the candidate biomarker TCF21 in gastric cancer. |
| Q86490397 | Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma |
| Q33757116 | ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-kB-dependent activation of Snail |
| Q39856973 | Ral overactivation in malignant peripheral nerve sheath tumors |
| Q37462315 | Reactive oxygen species and tumor metastasis |
| Q37342290 | Remodeling epithelial cell organization: transitions between front-rear and apical-basal polarity |
| Q26771696 | Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions |
| Q34643236 | Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis |
| Q36677690 | Role of microRNAs in breast cancer |
| Q54120638 | S100A6 promotes the proliferation and migration of cervical cancer cells via the PI3K/Akt signaling pathway. |
| Q34149920 | SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis. |
| Q26853644 | Salinomycin: a novel anti-cancer agent with known anti-coccidial activities |
| Q50527091 | Schwann-like cells differentiated from human dental pulp stem cells combined with a pulsed electromagnetic field can improve peripheral nerve regeneration. |
| Q37495453 | Self-organizing tissue-engineered constructs in collagen hydrogels |
| Q50480011 | Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming. |
| Q42200111 | Serine threonine receptor-associated protein (STRAP) plays a role in the maintenance of mesenchymal morphology |
| Q53321706 | Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines. |
| Q38484478 | Smad3 regulates Rho signaling via NET1 in the transforming growth factor-beta-induced epithelial-mesenchymal transition of human retinal pigment epithelial cells |
| Q35961794 | Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivity |
| Q47160414 | Snail1 is positively correlated with atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease |
| Q36430004 | Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells |
| Q38604585 | Suppression of CIP4/Par6 attenuates TGF-β1-induced epithelial-mesenchymal transition in NRK-52E cells |
| Q38288773 | Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells. |
| Q35985845 | TALENs-directed knockout of the full-length transcription factor Nrf1α that represses malignant behaviour of human hepatocellular carcinoma (HepG2) cells |
| Q37062041 | TGF-β1 regulates cell fate during epithelial-mesenchymal transition by upregulating survivin |
| Q38720774 | TRIM37 promotes epithelial‑mesenchymal transition in colorectal cancer |
| Q37728859 | TWISTing an embryonic transcription factor into an oncoprotein |
| Q36263617 | Targeted Inhibition of Snail Activity in Breast Cancer Cells by Using a Co(III) -Ebox Conjugate. |
| Q47701436 | Targeting Gas6/TAM in cancer cells and tumor microenvironment |
| Q54112424 | Telocinobufagin inhibits the epithelial-mesenchymal transition of breast cancer cells through the phosphoinositide 3-kinase/protein kinase B/extracellular signal-regulated kinase/Snail signaling pathway. |
| Q34756114 | Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells |
| Q34024731 | The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer |
| Q52841593 | The adaptor protein Cindr regulates JNK activity to maintain epithelial sheet integrity. |
| Q53219888 | The attenuation of epithelial to mesenchymal transition and induction of anoikis by gigantol in human lung cancer H460 cells. |
| Q38633203 | The epithelial-mesenchymal transition in cancer: a potential critical topic for translational proteomic research. |
| Q37401193 | The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies |
| Q37855124 | The extracellular matrix dimension of skeletal muscle development |
| Q37323439 | The impact of transgenic IGF-IR overexpression on mammary development and tumorigenesis |
| Q27320853 | The mechanics of metastasis: insights from a computational model |
| Q38255668 | The network of epithelial-mesenchymal transition: potential new targets for tumor resistance |
| Q30487545 | The neural crest epithelial-mesenchymal transition in 4D: a 'tail' of multiple non-obligatory cellular mechanisms |
| Q36849660 | The potential for liquid biopsies in the precision medical treatment of breast cancer |
| Q42342102 | The propensity for epithelial-mesenchymal transitions is dictated by chromatin states in the cancer cell of origin |
| Q38021684 | The rejuvenated scenario of epithelial-mesenchymal transition (EMT) and cancer metastasis |
| Q52861555 | The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells. |
| Q37734309 | The role of the bone marrow derived mesenchymal stem cells in colonic epithelial regeneration. |
| Q55332460 | The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines. |
| Q39414383 | Thymosin β 4 in colorectal cancer is localized predominantly at the invasion front in tumor cells undergoing epithelial mesenchymal transition |
| Q37505385 | Trafficking and cell migration |
| Q42361826 | Transcriptional inhibition in Schwann cell development and nerve regeneration |
| Q38763516 | Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGFβ-induced epithelial-to-mesenchymal transition |
| Q28237197 | Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits |
| Q28566030 | Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition |
| Q47140201 | Tumorigenesis as a process of gradual loss of original cell identity and gain of properties of neural precursor/progenitor cells. |
| Q33613560 | Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines |
| Q55109401 | Ultrastructural description of development and cell composition of primmorphs in the endemic Baikal sponge Lubomirskia baicalensis |
| Q30496088 | Unique precursors for the mesenchymal cells involved in injury response and fibrosis |
| Q34324979 | Unmasking epithelial-mesenchymal transition in a breast cancer primary culture: a study report |
| Q90584259 | Vesicle trafficking pathways that direct cell migration in 3D matrices and in vivo |
| Q48107131 | WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach. |
| Q41603090 | Wnt/PCP signaling controls intracellular position of MTOCs during gastrulation convergence and extension movements |
| Q51136044 | Zeb2: Inhibiting the inhibitors in Schwann cells. |
| Q21091183 | miR-200 enhances mouse breast cancer cell colonization to form distant metastases |
| Q38896392 | miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes. |
| Q45907906 | miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma. |
| Q37860250 | β-catenin as a potential key target for tumor suppression |